Byron Ingram v. Martin Marietta Long Term Disability Income Plan for Salaried Employees of Transferred Ge Operations, an Erisa Plan

244 F.3d 1109, 2001 Daily Journal DAR 3369, 25 Employee Benefits Cas. (BNA) 2477, 2001 Cal. Daily Op. Serv. 2728, 2001 U.S. App. LEXIS 5537, 2001 WL 322176
CourtCourt of Appeals for the Ninth Circuit
DecidedApril 4, 2001
Docket99-55581
StatusPublished
Cited by61 cases

This text of 244 F.3d 1109 (Byron Ingram v. Martin Marietta Long Term Disability Income Plan for Salaried Employees of Transferred Ge Operations, an Erisa Plan) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Byron Ingram v. Martin Marietta Long Term Disability Income Plan for Salaried Employees of Transferred Ge Operations, an Erisa Plan, 244 F.3d 1109, 2001 Daily Journal DAR 3369, 25 Employee Benefits Cas. (BNA) 2477, 2001 Cal. Daily Op. Serv. 2728, 2001 U.S. App. LEXIS 5537, 2001 WL 322176 (9th Cir. 2001).

Opinion

WILLIAM A. FLETCHER, Circuit Judge:

Byron Ingram is a former employee of General Electric Corporation, where he received as one of his benefits a long term disability insurance plan under the Employee Retirement Income Security Act (“ERISA”) administered by Metropolitan Life Insurance Company (“MetLife”). Ingram stopped working in 1998 and claims that since that time he has been totally disabled within the meaning of the plan. When MetLife terminated his disability benefits in 1997, Ingram brought suit in district court under 29 U.S.C. § 1132(a)(1)(B). He now appeals the district court’s grant of summary judgment to MetLife.

The central issue in this case is whether the district court should have reviewed MetLife’s denial of benefits under a de novo or an abuse of discretion standard. We hold that review should have been de novo and we reverse and remand for further proceedings.

I

In late 1992, Ingram developed chest pains and a cough severe enough to require eight days of hospitalization. He stopped working by March 18, 1993. In December of 1993, with the support of his physician, Ingram applied for and received benefits under the plan retroactive to October 9, 1993. The physician, Dr. James Kwako, reported that Ingram tested positive for coccidiomyosis (commonly known as “valley fever”) and listed his symptoms as “fatigue, dizziness, disequilibrium, headaches [and] cognitive dysfunction.” On the basis of these findings, Kwako described Ingram as “totally disabled.” Over the next four years, Kwako regularly attested in writing to Ingram’s total disability, diagnosing numerous ailments including chronic coccidiomyosis and Lyme disease. Ingram was also examined by a sleep specialist who diagnosed him with severe but treatable obstructive sleep apnea.

On February 18, 1997, Dr. Simon Jame-son, an infectious disease and internal medicine specialist, examined Ingram at MetLife’s request. Jameson found that although Ingram had several physical ailments, he was not “totally and permanently disabled.” He disputed Dr. Kwako’s finding of Lyme disease, and suggested that at least one of Ingram’s symptoms-his awkward gait-might have been factitious. MetLife sent Jameson’s report and all of Kwako’s findings to a third physician, Dr. Robert Porter, for independent review. Based on a review of Ingram’s medical records (but not an examination of Ingram himself), Porter reported to MetLife that there was “insufficient documentation of a condition of a severity to cause impairment in Mr. Ingram to preclude work.” Shortly thereafter, MetLife terminated Ingram’s disability benefits.

Ingram asked MetLife to review its decision, and further supported his claim *1112 with the findings of a psychologist, Dr. Sheila Bastien. Based on four evaluation sessions with Ingram, Bastien had prepared a fairly lengthy report on Ingram’s condition. She reported that Ingram’s “current diagnoses” were for chronic fatigue syndrome, Epstein-Barr, Lyme disease, valley fever, and multiple chemical sensitivity. To these, she added a psychological diagnosis of mild dementia, and concluded that “Byron Ingram is totally and completely disabled from any gainful employment at present.” MetLife had Bastien’s report reviewed by an independent psychiatrist, Dr. Robert Slack, who disputed Bastien’s diagnosis of dementia and stated that “a large number of residual occupational opportunities” remained open to Ingram. MetLife then reevaluated the termination of Ingram’s disability payments. It once again concluded that he was not totally disabled.

Ingram brought suit under ERISA. See 29 U.S.C. § 1132(a)(1)(B). The district court granted summary judgment against Ingram, from which he now appeals. We review a district court’s grant of summary judgment de novo. Weiner v. San Diego County, 210 F.3d 1025, 1028 (9th Cir.2000).

II

Depending upon the language of an ERISA plan, a district court reviews a plan administrator’s decision to deny benefits either de novo or for abuse of discretion. The de novo standard is appropriate “unless the benefit plan gives the administrator or fiduciary discretionary authority to determine eligibility for benefits or to construe the terms of the plan.” Firestone Tire & Rubber Co. v. Bruch, 489 U.S. 101, 115, 109 S.Ct. 948, 103 L.Ed.2d 80 (1989). As we recently stated in an en banc decision, “[A]n administrator ha[s] discretion only where discretion [is] ‘unambiguously retained.’ ” Kearney v. Standard Ins. Co., 175 F.3d 1084, 1090 (9th Cir.1999) (en banc) (quoting Bogue v. Ampex Corp., 976 F.2d 1319, 1325 (9th Cir.1992)). “[T]he default is that the administrator has no discretion, and the administrator has to show that the plan gives it discretionary authority in order to get any judicial deference to its decision.” Id. at 1089.

We therefore examine the text of MetLife’s disability plan to determine whether it “unambiguously” states that MetLife has “discretionary authority” in making benefits decisions. The plan states, in relevant part:

The carrier solely is responsible for providing the benefits under this Plan.... The carrier will make all decisions on claims and has reserved the right to examine medically an individual for whom claim is made at any time during the period of disability. Accordingly, the management and control of the operation and administration of claim procedures under the Plan, including the review and payment or denial of claims and the provision of full and fair review of claim denial pursuant to Section 503 of the Act, shall be vested in the carrier.

We discuss the statements upon which MetLife relies in the order in which they appear.

The plan first states that “[t]he carrier solely is responsible for providing the benefits under this Plan.” This statement makes clear that only MetLife, the “carrier,” pays benefits under the plan; that is, the insurance carrier rather than the employer is responsible for providing benefits. The statement says nothing about how benefit determinations are made.

Second, the plan states that “[t]he carrier will make all decisions on claims.... ” This statement cannot mean that MetLife makes all decisions in the sense that its decisions are final and unreviewable, for ERISA provides that a plan administrator’s decisions are always subject to judicial review. See 29 U.S.C. § 1132. Rather, this statement, like the first, allocates responsibility in the administration of the plan.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
244 F.3d 1109, 2001 Daily Journal DAR 3369, 25 Employee Benefits Cas. (BNA) 2477, 2001 Cal. Daily Op. Serv. 2728, 2001 U.S. App. LEXIS 5537, 2001 WL 322176, Counsel Stack Legal Research, https://law.counselstack.com/opinion/byron-ingram-v-martin-marietta-long-term-disability-income-plan-for-ca9-2001.